Related Experiment Video
Updated: Aug 10, 2026
04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
Minimally invasive radio-guided parathyroidectomy
Domenico Rubello1, Sandro Giannini, Chiara Martini
1Nuclear Medicine Service - PET Unit, "Santa-Maria-Della-Misericordia" Hospital, Istituto Oncologico Veneto (IOV), Viale Tre-Martiti, 140, 45100 Rovigo, Italy. rubello.domenico@azisanrovigo.it
Summary
Minimally invasive radio-guided parathyroidectomy (MIRP) is effective for primary hyperparathyroidism (P-HPT) when a solitary parathyroid adenoma is confirmed. This technique uses low-dose Sestamibi and offers a safe, short hospital stay.
Area of Science:
- Endocrinology
- Surgical Oncology
- Nuclear Medicine
Background:
- Primary hyperparathyroidism (P-HPT) is a common endocrine disorder.
- Surgical intervention is the definitive treatment for P-HPT.
- Minimally invasive techniques aim to reduce surgical morbidity.
Purpose of the Study:
- To evaluate the efficacy and safety of minimally invasive radio-guided parathyroidectomy (MIRP).
- To assess the outcomes of MIRP in a large cohort of patients with P-HPT.
- To identify patient selection criteria for successful MIRP.
Main Methods:
- Retrospective analysis of 253 patients undergoing MIRP for P-HPT.
- Preoperative imaging included Sestamibi scintigraphy and neck ultrasound.
- MIRP protocol utilized a low dose (1 mCi) of Sestamibi injected intraoperatively.
Main Results:
- MIRP was successfully performed in 96% of selected patients.
- No major intraoperative complications were observed; transient hypocalcemia occurred in 8.5%.
- Mean operative time was 35 minutes, with a mean hospital stay of 1.2 days.
Conclusions:
- MIRP is an effective treatment for P-HPT in patients with a solitary parathyroid adenoma and normal thyroid on imaging.
- Accurate preoperative imaging is crucial for MIRP success.
- Patients with Sestamibi-avid thyroid nodules should be excluded from MIRP due to potential false positives.
